The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches
Open accessAbstract
Introduction Epithelial circulating tumor cells (CTCs) are detectable in patients with non-small cell lung cancer (NSCLC). However, epithelial to mesenchymal transition, a widely reported prerequisite for metastasis, may lead to an underestimation of CTC number. We compared directly an epithelial marker-dependent (CellSearch) and a marker-independent (isolation by size of epithelial tumor cells [ISET]) technology platform for the ability to identify CTCs. Molecular characteristics of CTCs were also explored.Methods Paired peripheral blood samples were collected from 40 chemonäive, stages IIIA to IV NSCLC patients. CTCs were enumerated by Epithelial Cell Adhesion Molecule-based immunomagnetic capture (CellSearch, Veridex) and by filtration (ISET, RareCell Diagnostics). CTCs isolated by filtration were assessed by immunohistochemistry for epithelial marker expression (cytokeratins, Epithelial Cell Adhesion Molecule, epidermal growth factor receptor) and for proliferation status (Ki67).Results CTCs were detected using ISET in 32 of 40 (80%) patients compared with 9 of 40 (23%) patients using CellSearch. A subpopulation of CTCs isolated by ISET did not express epithelial markers. Circulating tumor microemboli (CTM, clusters of ≥ 3 CTCs) were observed in 43% patients using ISET but were undetectable by CellSearch. Up to 62% of single CTCs were positive for the proliferation marker Ki67, whereas cells within CTM were nonproliferative.Conclusions Both technology platforms detected NSCLC CTCs. ISET detected higher numbers of CTCs including epithelial marker negative tumor cells. ISET also isolated CTM and permitted molecular characterization. Combined with our previous CellSearch data confirming CTC number as an independent prognostic biomarker for NSCLC, we propose that this complementary dual technology approach to CTC analysis allows more complete exploration of CTCs in patients with NSCLC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While circulating tumor cells (CTCs) are considered a form of liquid biopsy, and we (31) and others (47) have reported on approaches for molecular analysis of CTCs, NSCLC patient CTCs cannot always be reliably identified (44, 48, 49).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature reviews. Cancer · doi:10.1038/nrc822 · Cited by 6,767
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Matera, J., Miller, M. C., Reuben, J. M., Doyle, G. V., Allard, W. J., Terstappen, L. W. M. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040766 · Cited by 4,602
Complex networks orchestrate epithelial–mesenchymal transitions
Thiery, J. P., & Sleeman, J. P. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1835 · Cited by 3,947
Collective cell migration in morphogenesis, regeneration and cancer
Friedl, P., & Gilmour, D. T. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2720 · Cited by 2,804
Allard, W. J., Matera, J., Miller, M. C., Repollet, M., Connelly, M. C., Rao, C., Tibbe, A. G. J., Uhr, J. W., & Terstappen, L. W. M. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0378 · Cited by 2,542
Bono, J. S. D., Scher, H. I., Montgomery, B., Parker, C. C., Miller, M. C., Tissing, H., Doyle, G. V., Terstappen, L. W. M. M., Pienta, K. J., & Raghavan, D. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0872 · Cited by 2,189
Cohen, S. J., Punt, C. J. A., Iannotti, N. O., Saidman, B. H., Sabbath, K. D., Gabrail, N. Y., Picus, J., Morse, M., Mitchell, E. P., Miller, M. C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.8923 · Cited by 1,876
Isolation of circulating tumor cells using a microvortex-generating herringbone-chip
Stott, S. L., Hsu, C., Tsukrov, D. I., Yu, M., Miyamoto, D. T., Waltman, B. A., Rothenberg, S. M., Shah, A. M., Smas, M. E., Korir, G. K., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012539107 · Cited by 1,657
Riethdorf, S., Fritsche, H. A., Müller, V., Rau, T., Schindlbeck, C., Rack, B. K., Janni, W., Coith, C., Beck, K., Jänicke, F., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1695 · Cited by 1,365
Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer
Cristofanilli, M., Hayes, D. F., Budd, G. T., Ellis, M. J., Stopeck, A., Reuben, J. M., Doyle, G. V., Matera, J., Allard, W. J., Miller, M. C., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.140 · Cited by 1,134
Cited by
Sorted by citations
Items 201–300 of 463
Eslami‐S, Z., Cortés‐Hernández, L. E., Glogovitis, I., Antunes‐Ferreira, M., D’Ambrosi, S., Kurma, K., Garima, F., Cayrefourcq, L., Best, M. G., Koppers‐Lalic, D., et al. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1209846 · Cited by 32
Development of new techniques and clinical applications of liquid biopsy in lung cancer management
Chen, K., He, Y., Wang, W., Yuan, X., Carbone, D. P., & Yang, F. (2024) · 中国科学通报：英文版 · doi:10.1016/j.scib.2024.03.062 · Cited by 31
Circulating Tumor Cells: Who is the Killer?
Paterlini-Bréchot, P. (2014) · Cancer Microenvironment · doi:10.1007/s12307-014-0164-4 · Cited by 30
Liquid Biopsy Promotes Non-Small Cell Lung Cancer Precision Therapy
Lü, J., & Han, B. (2018) · Technology in Cancer Research & Treatment · doi:10.1177/1533033818801809 · Cited by 29
Oulhen, M., Pawlikowska, P., Tayoun, T., Garonzi, M., Buson, G., Forcato, C., Manaresi, N., Aberlenc, A., Mezquita, L., Lécluse, Y., et al. (2021) · npj Precision Oncology · doi:10.1038/s41698-021-00203-1 · Cited by 29
Fanelli, M. F., de Oliveira, T. B., Braun, A. C., Corassa, M. P., Abdallah, E. A., Nicolau, U. R., Alves, V. S., Garcia, D., Calsavara, V. F., Kowalski, L. P., et al. (2017) · Head & Neck · doi:10.1002/hed.24899 · Cited by 28
Rossi, E. M. C., Aieta, M., Tartarone, A., Pezzuto, A., Facchinetti, A., Santini, D., Ulivi, P., Ludovini, V., Possidente, L., Fiduccia, P., et al. (2021) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-855 · Cited by 27
Kolesar, J., Peh, K. H., Thomas, L., Baburaj, G., Mukherjee, N., Kantamneni, R., Lewis, S. C., Pai, A., Udupa, K., Kumar, N. A. N., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01534-8 · Cited by 32
Circulating Tumour Cells: Detection and Application in Advanced Non-Small Cell Lung Cancer
Andrikou, K., Rossi, T., Verlicchi, A., Priano, I., Cravero, P., Burgio, M. A., Crinò, L., Bandini, S., Ulivi, P., & Delmonte, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216085 · Cited by 30
The potential diagnostic power of circulating tumor cell analysis for non-small-cell lung cancer
Ross, K., Pailler, E., Faugeroux, V., Taylor, M., Oulhen, M., Auger, N., Planchard, D., Soria, J., Lindsay, C. R., Besse, B., et al. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1111139 · Cited by 31
Сергеевна, З. Г., Kolovskaya, O. S., Ivanchenko, T. I., Zamay, T. N., Veprintsev, D. V., Grigorieva, V. L., Garanzha, I. V., Krat, A. V., Glazyrin, Y. E., Gargaun, A., et al. (2019) · Cancers · doi:10.3390/cancers11030351 · Cited by 27
Fluid Biopsy for Solid Tumors: A Patient’s Companion for Lifelong Characterization of Their Disease
Nieva, J. J., & Kühn, P. (2012) · Future Oncology · doi:10.2217/fon.12.91 · Cited by 29
Mariscal, J., Alonso‐Nocelo, M., Muinelo‐Romay, L., Barbazán, J., Vieito, M., Abalo, A., Gómez‐Tato, A., de Cal, M. C., García‐Caballero, T., Rodríguez, C., et al. (2016) · Scientific Reports · doi:10.1038/srep37820 · Cited by 27
Circulating tumor cells and microemboli can differentiate malignant and benign pulmonary lesions
Mascalchi, M., Maddau, C., Sali, L., Bertelli, E., Salvianti, F., Zuccherelli, S., Matucci, M., Borgheresi, A., Raspanti, C., Lanzetta, M. M., et al. (2017) · Journal of Cancer · doi:10.7150/jca.18418 · Cited by 27
Screening for early stage lung cancer and its correlation with lung nodule detection
Qian, F., Yang, W., Chen, Q., Zhang, X., & Han, B. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.12.123 · Cited by 27
Ilié, M., Hofman, V., Leroy, S., Cohen, C., Heeke, S., Cattet, F., Bence, C., Lalvée, S., Mouroux, J., Marquette, C., et al. (2018) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-0764 · Cited by 26
Liquid biopsy using extracellular vesicle–derived DNA in lung adenocarcinoma
Kim, I. A., Hur, J. Y., Kim, H. J., Lee, S. E., Kim, W. S., & Lee, K. Y. (2020) · Journal of Pathology and Translational Medicine · doi:10.4132/jptm.2020.08.13 · Cited by 26
Critical issues in the clinical application of liquid biopsy in non-small cell lung cancer
Manicone, M., Poggiana, C., Facchinetti, A., & Zamarchi, R. (2017) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.07.28 · Cited by 23
da Costa, A., Kohn, B., Gruber, A. D., & Klopfleisch, R. (2012) · The Veterinary Journal · doi:10.1016/j.tvjl.2012.08.021 · Cited by 26
Detection of circulating tumor cells in non-small cell lung cancer
Hamilton, G., & Rath, B. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.03.86 · Cited by 25
Vismara, M., Reduzzi, C., Silvestri, M., Murianni, F., Russo, G. L., Fortunato, O., Motta, R., Lanzoni, D., Giovinazzo, F., Miodini, P., et al. (2022) · Clinical Chemistry · doi:10.1093/clinchem/hvac019 · Cited by 25
Sawada, T., Watanabe, M., Fujimura, Y., Yagishita, S., Shimoyama, T., Maeda, Y., Kanda, S., Yunokawa, M., Tamura, K., Tamura, T., et al. (2015) · Cancer Science · doi:10.1111/cas.12868 · Cited by 25
Possible applications of circulating tumor cells in patients with non small cell lung cancer
Tartarone, A., Rossi, E. M. C., Lerose, R., Mambella, G., Calderone, G., Zamarchi, R., & Aieta, M. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.05.027 · Cited by 25
Enrichment, Isolation and Molecular Characterization of EpCAM-Negative Circulating Tumor Cells
Lampignano, R., Schneck, H., Neumann, M., Fehm, T. N., & Neubauer, H. J. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-55947-6_10 · Cited by 27
EGFR expression in circulating tumor cells from high-grade metastatic soft tissue sarcomas
Braun, A. C., de Mello, C. A. L., Corassa, M. P., Abdallah, E. A., Urvanegia, A. C. M., Alves, V. S., Flores, B. C. T., Díaz, M., Nicolau, U. R., Silva, V. S. E., et al. (2018) · Cancer Biology & Therapy · doi:10.1080/15384047.2018.1433498 · Cited by 25
Tong, B., Xu, Y., Zhao, J., Chen, M., Zhong, W., Xing, J., & Wang, M. (2018) · Thoracic Cancer · doi:10.1111/1759-7714.12631 · Cited by 25
Yang, D., Yang, X., Li, Y., Zhao, P., Fu, R., Ren, T., Hu, P., Wu, Y., Yang, H., & Guo, N. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02401-0 · Cited by 27
Heterogeneous Circulating Tumor Cells in Sarcoma: Implication for Clinical Practice
Agnoletto, C., Caruso, C., & Garofalo, C. (2021) · Cancers · doi:10.3390/cancers13092189 · Cited by 27
Yin, J., Wang, Y., Yin, H., Chen, W., Jin, G., Ma, H., Dai, J., Chen, J., Jiang, Y., Wang, H., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137076 · Cited by 24
An Effective Approach for Robust Lung Cancer Cell Detection
Pan, H., Xu, Z., & Huang, J. (2015) · Lecture notes in computer science · doi:10.1007/978-3-319-28194-0_11 · Cited by 23
Circulating Tumor Cells in Esophageal Cancer
Hoeppner, J., & Kulemann, B. (2017) · Oncology Research and Treatment · doi:10.1159/000478863 · Cited by 23
Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design
Kejík, Z., Kaplánek, R., Dytrych, P., Masařík, M., Veselá, K., Abramenko, N., Hoskovec, D., Vašáková, M., Králová, J., Pavel Martasek, E., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111879 · Cited by 23
Yang, Y., Kong, Y., Li, G.-X., Wang, Y., Ye, D., & Dai, B. (2018) · British Journal of Urology · doi:10.1111/bju.14642 · Cited by 22
Kallergi, G., Kontopodis, E., Ntzifa, A., Jordana‐Ariza, N., Karachaliou, N., Pantazaka, E., Charalambous, H., Psyrri, A. K., Tsaroucha, E. G., Boukovinas, I., et al. (2022) · Cancers · doi:10.3390/cancers14061574 · Cited by 22
Chudasama, D. Y., Freydin, M., Freidin, M. B., Leung, M., Montero, Á., Rice, A. J., Nicholson, A. G., Karteris, E., Anikin, V., & Lim, E. K. S. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.12.28 · Cited by 22
Markou, A. N., Tzanikou, E., Kallergi, G., Pantazaka, E., Georgoulias, V., Kotsakis, A. P., & Lianidou, E. S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.641978 · Cited by 22
Broncy, L., Njima, B. B., Méjean, A., Béroud, C., Romdhane, K. B., Ilié, M., Hofman, V., Muret, J. C., Hofman, P. M., Chaabouni-Bouhamed, H., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25102 · Cited by 22
Cui, Y., Li, J., Liu, X., Gu, L., Lyu, M., Zhou, J., Zhang, X., Liu, Y., Zhu, H., Zhang, T., et al. (2022) · Cancers · doi:10.3390/cancers14174121 · Cited by 20
Bitting, R. L., Healy, P. N., Halabi, S., George, D. J., Goodin, M., & Armstrong, A. J. (2015) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2014.09.002 · Cited by 21
Circulating Tumor Cell and Cell-free Circulating Tumor DNA in Lung Cancer
Nurwidya, F., Zaini, J., Putra, A. C., Andarini, S., Hudoyo, A., Syahruddin, E., & Yunus, F. (2016) · Chonnam Medical Journal · doi:10.4068/cmj.2016.52.3.151 · Cited by 21
Perioperative detection of circulating tumour cells in patients with lung cancer
Chudasama, D. Y., Burnside, N., Beeson, J., Karteris, E., Rice, A. J., & Anikin, V. (2017) · Oncology Letters · doi:10.3892/ol.2017.6366 · Cited by 21
Russo, T. D. B., Pepe, F., Gristina, V., Gottardo, A., Russo, G., Scimone, C., Palumbo, L., Busuito, G., Incorvaia, L., Guerry, J. A., et al. (2025) · Future Oncology · doi:10.1080/14796694.2025.2542051 · Cited by 20
Yin, W., Zhu, J., Ma, B., Jiang, G., Zhu, Y., He, W., Yang, Y., & Zhang, Z. (2020) · Small · doi:10.1002/smll.202001695 · Cited by 20
Abdallah, E. A., Silva, V. S. E., Braun, A. C., Gasparini, V. A., Kupper, B. E. C., Tariki, M. S., Tarazona, J. G. R., Takahashi, R. M., Aguiar, S., & Chinen, L. T. D. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100932 · Cited by 21
Carvalho, Â., Ferreira, G., Seixas, D., Guimarães‐Teixeira, C., Henrique, R., Monteiro, F. J., & Jerónimo, C. (2021) · Cancers · doi:10.3390/cancers13092101 · Cited by 20
Significance of Circulating Tumor Cells in Soft Tissue Sarcoma
Nicolazzo, C., & Gradilone, A. (2015) · Analytical Cellular Pathology · doi:10.1155/2015/697395 · Cited by 20
The emerging role of circulating tumor cells in cancer management.
Li, X., Dong, M., Zang, X.-Y., Li, M.-Y., Zhou, J., Ma, J., & Wang, G.-Y. (2020) · PubMed Central · Cited by 20
CK-coated magnetic-based beads as a tool to isolate circulating tumor cells (CTCs) in human tumors.
Mayo, C., Ortega, F. G., Giménez-Capitán, A. A., Molina‐Vila, M. Á., Serrano, M. J., Viteri, S., Costa, C., Gascó, A., Bertrán-Alamillo, J., Karachaliou, N., et al. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2218-6751.2013.02.06 · Cited by 20
Sun, W., Jia, C., Huang, T., Sheng, W., Li, G., Zhang, H., Jing, F., Jin, Q., Zhao, J., Li, G., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075865 · Cited by 19
Papadaki, M. A., Messaritakis, I., Fiste, O., Souglakos, J., Politaki, E., Kotsakis, A. P., Georgoulias, V., Mavroudis, D., & Agelaki, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020925 · Cited by 19
Zeng, C. D. D., Jin, C., Gao, C., Xiao, A. T., Tong, Y. X., & Zhang, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.769203 · Cited by 19
Vora, N., Shekar, P., Hanulia, T. O., Esmail, M. Y., Patra, A., & Georgakoudi, I. (2024) · Lab on a Chip · doi:10.1039/d3lc00694h · Cited by 21
Circulating Polyploid Giant Cancer Cells, a Potential Prognostic Marker in Patients with Carcinoma
Chinen, L. T. D., Torres, J. A., Calsavara, V. F., Brito, A. B. C., Silva, V. S. E., Novello, R., Fernandes, T. C., Decina, A., Dachez, R., & Paterlini-Bréchot, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25189841 · Cited by 19
Liquid Biopsies in Lung Cancer: Four Emerging Technologies and Potential Clinical Applications
Chudasama, D. Y., Katopodis, P., Stone, N., Haskell, J. A., Sheridan, H., Gardner, B., Urnovitz, H. B., Schütz, E., Beck, J., Hall, M., et al. (2019) · Cancers · doi:10.3390/cancers11030331 · Cited by 19
Woestemeier, A., Harms-Effenberger, K., Karstens, K.-F., Konczalla, L., Ghadban, T., Uzunoglu, F. G., Izbicki, J. R., Bockhorn, M., Pantel, K., & Reeh, M. (2020) · Cancers · doi:10.3390/cancers12030718 · Cited by 19
Bouhlel, L., Hofman, V., Maschi, C., Ilié, M., Allégra, M., Marquette, C., Audigier-Valette, C., Thariat, J., & Hofman, P. M. (2017) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2017.1398089 · Cited by 19
Zhao, Y., Zhang, X., Bai, J., Jia, H.-Y., Chen, M., & Wang, J. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c04366 · Cited by 18
Role of circulating tumor cells and cancer stem cells in hepatocellular carcinoma
Nel, I., David, P., Gerken, G., Schlaak, J., & Hoffmann, A.-C. (2014) · Hepatology International · doi:10.1007/s12072-014-9539-3 · Cited by 18
The prognostic role of circulating tumor cells in lung cancer
Normanno, N., Luca, A. D., Gallo, M., Chicchinelli, N., & Rossi, A. (2016) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2016.1202767 · Cited by 18
Tong, B., & Wang, M. (2019) · Future Oncology · doi:10.2217/fon-2018-0548 · Cited by 18
Ikeda, M., Koh, Y., Teraoka, S., Sato, K., Kanai, K., Hayata, A., Tokudome, N., Akamatsu, H., Ozawa, Y., Akamatsu, K., et al. (2020) · Cancer Medicine · doi:10.1002/cam4.2846 · Cited by 18
Castle, J., Morris, K. L., Pritchard, S. A., & Kirwan, C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175647 · Cited by 18
Ruano, A. P. C., Guimarães, A. P. G., Braun, A. C., Flores, B. C. T., Tariki, M. S., Abdallah, E. A., Torres, J. A., Nunes, D. N., Gonçalves, B. T., de Lima, V. C. C., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314687 · Cited by 17
Purcell, E., Niu, Z., Owen, S., Grzesik, M., Radomski, A., Kaehr, A., Onukwugha, N., Winkler, H. F., Ramnath, N., Lawrence, T. S., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113687 · Cited by 17
Circulating tumor cells as lung cancer biomarkers.
Wong, M. P. (2012) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2072-1439.2012.10.05 · Cited by 18
Circulating Tumor Cells in Esophageal Squamous Cell Carcinoma – Mini Review
Shi, Y., Ge, X., Ju, M., Zhang, Y., Di, X., & Liang, L. (2021) · Cancer Management and Research · doi:10.2147/cmar.s337489 · Cited by 17
Torres, J. A., Brito, A. B. C., Silva, V. S. E., Messias, I. M., Braun, A. C., Ruano, A. P. C., Buim, M. E. C., Carraro, D. M., & Chinen, L. T. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241511958 · Cited by 16
Targeting circulating tumor cells to prevent metastases
Gostomczyk, K., Marsool, M. D. M., Tayyab, H., Pandey, A., Borowczak, J., Macome, F., Chacón, J. A., Dave, T., Maniewski, M., & Szylberg, Ł. (2023) · Human Cell · doi:10.1007/s13577-023-00992-6 · Cited by 16
Koren, A., Sodja, E., Rijavec, M., Jež, M., Kovač, V., Korošec, P., & Čufer, T. (2015) · Cellular Oncology · doi:10.1007/s13402-015-0238-4 · Cited by 16
Liu, M., Li, R., Tang, Y., Chang, J., Han, R., Zhang, S., Jiang, N., & Ma, F. (2017) · Oncology Letters · doi:10.3892/ol.2017.5724 · Cited by 16
Molecular profiling of lung cancer
Minárik, M. (2016) · Onkologie · doi:10.36290/xon.2016.003 · Cited by 16
Interrelationships of Circulating Tumor Cells with Metastasis and Thrombosis: Role of MicroRNAs
Xue, J., Xie, V. K., Wang, P., Cui, J., Gao, Y., & Lu, Z. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140128220152 · Cited by 16
Diagnostic value of bronchoalveolar lavage fluid and serum tumor markers for lung cancer
Zhang, X., Wang, H., Liu, X., Liu, K., Li, Y., & Xu, H. (2016) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.162111 · Cited by 16
Ouyang, Y., Kim, T. J., & Pratx, G. (2016) · Molecular Imaging · doi:10.1177/1536012116646489 · Cited by 16
Po, J. W., Roohullah, A., Lynch, D. T., DeFazio, A., Harrison, M., Harnett, P. R., Kennedy, C. J., Kennedy, C. J., SOUZA, P. D., & Becker, T. M. (2018) · Journal of Circulating Biomarkers · doi:10.33393/jcb.2018.2090 · Cited by 16
Clinical Significance of a Circulating Tumor Cell-based Classifier in Stage IB Lung Adenocarcinoma
Ren, L., Zhong, X., Liu, W., Xu, D., Lei, Y., Zhou, J., Jiang, W., He, Q., Sun, Y., & Ke, Z. (2021) · Annals of Surgery · doi:10.1097/sla.0000000000004780 · Cited by 15
Rizzo, M. I., Ralli, M., Nicolazzo, C., Gradilone, A., Carletti, R., Gioia, C. R. T. D., VINCENTIIS, M. D., & Greco, A. (2020) · Oncology Letters · doi:10.3892/ol.2020.11528 · Cited by 15
Imaging Biomarkers of Tumour Proliferation and Invasion for Personalised Lung Cancer Therapy
Marcu, L. G. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10040222 · Cited by 15
Liquid biopsy in non-small cell lung cancer—current status and future outlook—a narrative review
Smolle, E., Taucher, V., Lindenmann, J., Pichler, M., & Smolle-Jüettner, F.-M. (2021) · Translational Lung Cancer Research · doi:10.21037/tlcr-21-3 · Cited by 15
Ouyang, R., Wu, S., Zhang, B., Wang, T., Yin, B., Huang, J., Wei, W., Huang, M., Zhang, M., Wang, Y., et al. (2021) · Cancer Biomarkers · doi:10.3233/cbm-210099 · Cited by 15
Silva, V. S. E., Abdallah, E. A., Flores, B. C. T., Braun, A. C., Costa, D. D. J. F., Ruano, A. P. C., Gasparini, V. A., Silva, M. L. G., Mendes, G. G., Claro, L. C. L., et al. (2021) · Cells · doi:10.3390/cells10061539 · Cited by 15
Katsarou, S. D., Messaritakis, I., Voumvouraki, A., Kakavogiannis, S., Kotsakis, A. P., Alkahtani, S. H., Stournaras, C., Martin, S. S., Georgoulias, V., & Kallergi, G. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12020154 · Cited by 15
Bitting, R. L., & Armstrong, A. J. (2013) · The Cancer Journal · doi:10.1097/ppo.0b013e31827e0b9c · Cited by 15
Wenta, R., Richert, J., Muchlińska, A., Senkus, E., Suchodolska, G., Łapińska‐Szumczyk, S., Domżalski, P., Miszewski, K., Matuszewski, M., Dziadziuszko, R., et al. (2024) · Cytometry Part A · doi:10.1002/cyto.a.24906 · Cited by 14
Methods for detection of circulating cells in non-small cell lung cancer
Han, Y. (2014) · Frontiers in bioscience · doi:10.2741/4255 · Cited by 14
Sonn, C.-H., Cho, J. H., Kim, J., Kang, M. S., Lee, J., & Kim, J. (2017) · Oncology Letters · doi:10.3892/ol.2017.5772 · Cited by 14
Huang, M., Ma, Y., Lv, C., Li, S., Lu, F., Zhang, S., Wang, D. D., Lin, P. P., & Yang, Y. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s330361 · Cited by 14
Xu, W., Wu, B., Fu, L., Chen, J., Wang, Z., Huang, F., Chen, J., Zhang, M., Zhang, Z., Lin, J., et al. (2017) · Oncology Reports · doi:10.3892/or.2017.5613 · Cited by 14
Ilié, M., Mazières, J., Chamorey, E., Heeke, S., Benzaquen, J., Thamphya, B., Boutros, J., Tiotiu, A. I., Fayada, J., Cadranel, J. L., et al. (2021) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2021.01.1617 · Cited by 14
Werner, S. L., Graf, R. P., Landers, M. A., Valenta, D. T., Schroeder, M. J., Greene, S. B., Bales, N., Dittamore, R. V., & Marrinucci, D. C. (2015) · Journal of Circulating Biomarkers · doi:10.33393/jcb.2015.2053 · Cited by 14
Isolation and typing techniques for circulating tumor cells
Wu, S., Rong, S., He, A., Xia, Y., & Xu, F. (2026) · Biomarker Research · doi:10.1186/s40364-026-00901-7 · Cited by 14
Jie, X., Zhang, M., Du, M., Cai, Q., Cong, Q., Xu, C., & Zhang, X. (2022) · Translational Cancer Research · doi:10.21037/tcr-22-529 · Cited by 13
Kontić, M., Ognjanovic, M., Jovanović, D. M., Kontic, M., & Ognjanovic, S. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.04.02 · Cited by 13
Lin, A. Y., Wang, D. D., Li, L., & Lin, P. P. (2021) · Cancers · doi:10.3390/cancers13205108 · Cited by 13
Tamminga, M., Andree, K., van den Bos, H., Hiltermann, T. J. N., Mentink, A., Spierings, D. C. J., Lansdorp, P. M., Timens, W., Schuuring, E. M. D., Terstappen, L. W. M. M., et al. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01634-0 · Cited by 14
Circulating tumor-derived biomarkers in lung cancer.
Taenzer, A., Alix‐Panabières, C., Wikman, H., & Pantel, K. (2012) · PubMed Central · doi:10.3978/j.issn.2072-1439.2012.08.17 · Cited by 13
Trombetta, D., Sparaneo, A., Fabrizio, F. P., & Muscarella, L. A. (2016) · Lung Cancer Management · doi:10.2217/lmt-2016-0006 · Cited by 14
Engineering Concepts in Stem Cell Research
Narayanan, K., Mishra, S., Singh, S., Pei, M., Gulyás, B. Z., & Padmanabhan, P. (2017) · Biotechnology Journal · doi:10.1002/biot.201700066 · Cited by 13
Milaki, G., Messaritakis, I., Koinis, F., Kotsakis, A. P., Apostolaki, S., Dermitzaki, E., Perraki, M., Hatzidaki, D., & Georgoulias, V. (2017) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-017-3339-0 · Cited by 13
Zafeiriadou, A., Kollias, I., Londra, T., Tsaroucha, E., Georgoulias, V., Kotsakis, A. P., Lianidou, E. S., & Markou, A. N. (2022) · Cancers · doi:10.3390/cancers14133237 · Cited by 12
Metadata
- Authors
- Krebs, M. G., Hou, J.-M., Sloane, R., Lancashire, L., Priest, L., Nonaka, D., Ward, T. H., Backen, A., Clack, G., Hughes, A., Ranson, M., Blackhall, F. H., & Dive, C.
- Affiliations
- Manchester Academic Health Science Centre (GB)
- Cancer Research UK Manchester Institute (GB)
- The Christie NHS Foundation Trust (GB)
- University of Manchester (GB)
- AstraZeneca (United Kingdom) (GB)
- Corresponding author
- Dive, Caroline
- ORCID
- Venue
- Journal of Thoracic Oncology
- Publisher
- Elsevier BV
- Published
- 2012-02
- Volume
- 7
- Issue
- 2
- Pages
- 306-315
- ISSN
- 1556-0864 (ISSN-L)
- OpenAlex
- W2037607269
- Cited by
- 463
- References
- 40
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 22 · 2023: 23 · 2022: 29 · 2021: 45 · 2020: 39 · 2019: 38 · 2018: 40 · 2017: 47 · 2016: 51 · 2015: 34 · 2014: 27 · 2013: 31 · 2012: 18
- FWCI
- 8.48
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of Thoracic Oncology (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Funders
- AstraZeneca
- Cancer Research UK (C147/a12328)
- Academy of Medical Sciences (AMS-SGCL7-Krebs)
- European Commission
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
- Keywords
- circulating tumor cells, non-small cell lung cancer, epithelial-mesenchymal transition, CellSearch, circulating tumor microemboli, epithelial markers, Ki-67 proliferation index, EpCAM, cytokeratin, epidermal growth factor receptor, CTC enumeration, prognostic factors
- MeSH terms
- Adenocarcinoma, Aged, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Cell Separation, Epithelial Cells, Female, Humans, Lung Neoplasms, Male, Middle Aged, Neoplastic Cells, Circulating, Prognosis, Prospective Studies, Biomarkers, Tumor, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
